Stories about Genetics

Subscribe to topic

Subscribe to Genetics

04.12.2019 – 12:22
APR Applied Pharma Research s.a.
FDA Grants Orphan Drug Designation to APR Applied Pharma Research's Investigational Drug for the Treatment of Epidermolysis Bullosa
Balerna, Switzerland (ots/PRNewswire) - APR Applied Pharma Research sa ("APR"), the Swiss pharma company focused in niche and rare therapeutic areas, announces that the US Food and Drug Administration (the "FDA") has granted Orphan Drug Designation for its investigational drug code-named APR-TD011 for treatment of ...
25.10.2019 – 10:03
Helmholtz Zentrum München
Helmholtz Zentrum München allies with Eli Lilly and Company to discover new targets for pancreatic beta cell regeneration in the treatment of diabetes
Learn more about Helmholtz Zentrum München
21.10.2019 – 17:03
Helmholtz Zentrum München
Identification of a ferroptosis suppressor protein allows for new anticancer treatment approach
Read more about Helmholtz Zentrum München
17.10.2019 – 11:13
Technische Universität München
How roots grow hair: "Smoke detectors" in plants also control the growth of root hair
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35739/ High resolution images: https://mediatum.ub.tum.de/1521816 NEWS RELEASE How roots grow hair "Smoke detectors" in plants also control the growth of ...
14.10.2019 – 17:27
Helmholtz Zentrum München
Discovery of potential novel therapeutic target for non-alcoholic fatty liver disease
Read the paper
01.10.2019 – 19:39
Novo Nordisk A/S
Novo Nordisk and Noom to partner around digital health solutions to help people with obesity lose weight and keep it off
Bagsværd, Denmark (ots/PRNewswire) - Novo Nordisk, a global healthcare company, and Noom, a leading behaviour change company, today announced a collaboration on digital health solutions focusing on weight management and education, with the aim of improving the lives of people living with obesity. The collaboration ...
10.09.2019 – 09:40
Grünenthal Group
Grünenthal and Mesoblast Enter Strategic Partnership for Europe and Latin America to Develop and Commercialise Innovative Cell Therapy for the Treatment of Chronic Low Back Pain
Aachen, Germany, and Melbourne, Australia (ots) - Grünenthal, a global leader in pain management, and Mesoblast Limited (ASX: MSB; Nasdaq: MESO), a world leader in allogeneic cellular medicines for inflammatory diseases, today announced that they have entered into a strategic partnership to develop and ...
17.07.2019 – 17:08
Technische Universität München
The physiology of survival: for bacteria, the neighbors co-determine which cell dies first
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35582/ High resolution images: https://mediatum.ub.tum.de/1513622 NEWS RELEASE The physiology of survival For bacteria, the neighbors co-determine which ...
11.06.2019 – 14:13
nova-Institut GmbH
PRESS RELEASE: Necessary measures to achieve a level-playing field for bio-based products
Necessary measures to achieve a level-playing field for bio-based products Over the last three years the STAR4BBI project has studied policy and standardisation hurdles that bio-based industries face. During the recent stakeholders' workshop in Cologne, a set of seven measures to ...
Subscribe to nova's mailing list
03.06.2019 – 09:00
Seed-X
Seed-X and TomaTech Use AI to Speed Up Breeding of Superior Quality Hybrid Tomatoes
Rehovot, Israel (ots/PRNewswire) - Seed-X, the innovative agtech company that improves seed qualification during the breeding process, and TomaTech, the dynamic and innovative tomato seed breeding company, have announced a new pilot of GeNee Breeder(TM), the first and only seed phenotype analysis system that offers breeders reliable real-time classification of a wide ...
08.05.2019 – 15:25
Helmholtz Zentrum München
2
Specific identification of chronic lung disease in premature babies
Would you like to read the message online? This way!
03.05.2019 – 13:52
Helmholtz Zentrum München
What the wheat genome tells us about wars
Would you like to read the message online? This way!
02.05.2019 – 14:08
Helmholtz Zentrum München
Pluripotency or differentiation - that is the question
Would you like to read the message online? This way!
15.04.2019 – 11:14
Helmholtz Zentrum München
RNA Transport in Neurons - Staufen2 detects its target transcripts in a complex manner
Read article here online
12.04.2019 – 11:45
Helmholtz Zentrum München
2
CD30 - from witness to culprit
Meldung hier online lesen
11.04.2019 – 09:00
Sophia Genetics
SOPHiA GENETICS Achieves CE-IVD Milestone for Its Solid Tumor Solution for Accurate Cancer Detection
Lausanne, Switzerland (ots/PRNewswire) - SOPHiA GENETICS, global leader in Data-Driven Medicine, announced today the CE-IVD marking of its Solid Tumor Solution (STS), a new step in the fight against cancer. This standardized molecular diagnostic application precisely detects and characterizes all types of genomic ...
02.04.2019 – 09:25
Helmholtz Zentrum München
New machine learning model describes dynamics of cell development
From their birth through to their death, cells lead an eventful existence. Thanks to single-cell genomics, their destiny in large cell populations can now be analyzed. However, this method destroys the cell, which makes it difficult to draw conclusions about the dynamics of cell ...
Would you like to read the message online? This way!
14.02.2019 – 09:00
Debiopharm International SA
Debiopharm International SA Initiates FUZE, a Clinical Trial Phase II study evaluating Debio 1347 in Advanced Solid Tumors harboring an FGFR fusion
24.01.2019 – 14:01
Merck KGaA
Merck Grants Exclusive License to Vertex for Two DNA Damage Response Inhibitors
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK- or US-based media - Exclusive license grants Vertex one clinical and one pre-clinical DNA-PK inhibitor for use in gene-editing applications in six specific genetic disease areas - Merck retains the rights to both compounds in all other disease areas, including oncology - Merck retains the rights to utilize and ...
16.01.2019 – 11:00
Lipotype
Lipotype announces "Lipidomics Excellence Award" for Breakthrough Lipidomics Projects / Call for Applications open till 30 March, 2019
Dresden/Germany (ots) - The international scientific community is called to submit applications for the premiere of the world's first award for cutting edge contributions to the progress of life sciences through lipidomics, the 2019 "Lipidomics Excellence Award" (LEA) until 30 March, 2019. Prof. Dr. Kai Simons, ...
04.01.2019 – 06:01
Sophia Genetics
SOPHiA GENETICS Raises $77 Million to Accelerate the Democratization of Data-Driven Medicine
San Francisco (ots/PRNewswire) - SOPHiA GENETICS, a leading health tech company, announced today the closing of a $77 million investment round to accelerate the democratization of Data-Driven Medicine. The round was led by Generation Investment Management, a pioneer of sustainable investing, with offices in London and San Francisco. Generation were joined by Idinvest ...
20.12.2018 – 16:01
Merck KGaA
Merck Announces EMA Orphan Drug Designation for Bifunctional Immunotherapy M7824 in Biliary Tract Cancer
Darmstadt, Germany (ots/PRNewswire) - The information contained is not intended for distribution in the USA, Canada or the UK - European Medicine Agency (EMA) grants M7824, an investigational bifunctional immunotherapy, orphan drug designation in biliary tract cancer (BTC) - EMA orphan drug designation for M7824 in ...
10.12.2018 – 16:21
Merck KGaA
Merck Announces FDA Orphan Drug Designation for Bifunctional Immunotherapy M7824 in Biliary Tract Cancer
Darmstadt, Germany (ots/PRNewswire) - The information contained is not intended for distribution in the USA, Canada or the UK - FDA grants M7824, an investigational bifunctional immunotherapy, orphan drug designation in biliary tract cancer - First regulatory designation for M7824 following recent presentation of ...
28.11.2018 – 16:04
Technische Universität München
The virus detectives: The secret of brown trout dying uncovered
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/detail/article/35106/ High resolution images: https://mediatum.ub.tum.de/1464488 NEWS RELEASE The virus detectives The secret of brown trout dying uncovered Every summer in Southern Germany, Austria and Switzerland, ...
28.11.2018 – 13:34
LEH Pharma
New Data Indicate That EyeMax Mono, a Lens Tailored Specifically for Patients With Dry Age-related Macular Degeneration (AMD), Offers Significant Improvement in Visual Function
London (ots/PRNewswire) - EyeMax Mono implantation results in an improved mean visual acuity of 18 ETDRS letters and 57% increase in mean reading speed LEH Pharma Ltd, a leading provider of innovative technologies for macular disorders, today announces new data published in the Journal of Refractive Surgery[1], ...
05.11.2018 – 17:07
Helmholtz Zentrum München
Tackling Big Data - new graduate school for Data Science in Munich
As a result of digitalization, research is producing ever larger and more complex data sets. While these hold great potential for example for biomedicine, energy research, geo-research or robotics, they also need to be managed and interpreted. To address this need, the Munich School for Data Science @ Helmholtz, TUM & LMU (MuDS) has ...
Online version
05.11.2018 – 12:00
Sysmex Inostics GmbH
Sysmex Inostics OncoBEAM(TM) circulating tumor DNA technology demonstrates superior response prediction for advanced pancreatic cancer over standard-of-care protein biomarkers
Hamburg, Germany (ots) - Recent data published in Annals of Oncology (https://academic.oup.com/annonc/advance-article/doi/10.1093/annonc/mdy417/5139593) from a study conducted by Sysmex Inostics and University of Munich indicate that circulating tumor DNA (ctDNA) may offer clinicians higher-resolution information ...

12Next